INS and Hyperbilirubinemia: Ruholamin et al. reported no significant differences in the prevalences of gestational complications, preterm birth, hyperbilirubinemia, NICU admission, macrosomia, SGA, or neonatal hypoglycemia between the metformin and insulin groups.